At least three-quarters of U.S. voters favor keeping the Bayh-Dole Act to back innovation and research, but are concerned that it may be “misused […]
Poll: U.S. voters support the Bayh-Dole Act, but fear its misuse by lawmakers Read More »
The Biotechnology Innovation Organization (BIO) is surveying biotech companies about their interactions with the Food and Drug Administration (FDA), with the goal of improving
BIO surveying biotech firms on how to improve communications with the FDA Read More »
Dubbed one of the most significant and inspiring pieces of legislation in the history of innovation and invention in the United States, the Bayh-Dole
Bayh-Dole Coalition awards 5 innovators for groundbreaking discoveries Read More »
Jennifer Camel-Toueg’s son was not getting better. “Alex, who is now 20 years old, was diagnosed with ulcerative colitis at 17,” recalled Camel-Toueg. “With
TrueTrials simplifies finding FDA-authorized cell therapy clinical trials Read More »
Drug price controls in the Inflation Reduction Act (IRA) harm the development of new drugs, according to Sept. 20 testimony in Congress from John
BIO Vice Chair John F. Crowley to Congress: IRA reduces access to innovative drugs Read More »
The Inflation Reduction Act (IRA) includes a misguided plan to control prices that will only result in costlier medicine and reduced access, lawmakers and
Why drug price controls ‘risk the future of investment’ in R&D Read More »
People six months and older should have one of the updated COVID-19 vaccines released by Pfizer-BioNTech and Moderna, under the recommendation approved Sept. 12
CDC recommends everyone get the updated COVID-19 vaccines Read More »
Antimicrobial resistance (AMR) continues to raise concerns among the medical and scientific community. But, AMR could be combatted in part with vaccines, said experts
AMR vaccines might be a new tool to fight this global health threat Read More »
Rachel King, the CEO of the Biotechnology Innovation Organization (BIO), shares insights about drug price controls and other challenges to the biotech industry that
BIO’s Rachel King weighs in on IRA and the biotech industry in new podcasts Read More »
The Federal Trade Commission (FTC) on Sept. 1 settled a lawsuit that was threatening to “chill investment, with predictable and unwelcome results for innovation
FTC settles suit that would have been harmful to biotech innovation Read More »
